Authors
Ralph Briner, Philippe Mathys, Lucia Zampaglione, Jean-Louis Frossard
Published in
Revue medicale suisse. Volume 22. Issue 972. Pages 1330-1334. Aug 26, 2026.
Abstract
Gastroesophageal reflux disease (GERD) is a common condition that requires a modern, evidence-based diagnostic approach. The Lyon Consensus 2.0 redefines "actionable GERD" by incorporating objective endoscopic and functional criteria, while the American Society for Gastrointestinal Endoscopy's 2025 guidelines further clarify diagnostic and therapeutic strategies. Although typical GERD symptoms remain central to the clinical evaluation, they are insufficient on their own to establish a definitive diagnosis. Ambulatory reflux monitoring, including prolonged wireless pH monitoring with the Bravo capsule and pH-impedance testing, allows for a more accurate characterization of reflux burden and symptom association. Management is based on proton pump inhibitors, lifestyle and dietary modifications, and, in selected cases, interventional treatments.
PMID:
42682110
Bibliographic data and abstract were imported from PubMed on 02 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 2
- Comments 0